Paroxetine
Product Images NDC 42858-705

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Paroxetine (NDC 42858-705). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rhodes Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Paroxetine 01)

Chemical structure diagram of Paroxetine Hydrochloride, showing its molecular arrangement with labeled atoms including fluorine (F) and oxygen (O) in the bicyclic and piperidine rings.*

FDA Label Image

Principal Display Panel (12.5 mg Tablet Bottle Label)

A chart showing fold change and 90% confidence intervals in pharmacokinetic parameters (Cmax and AUC) of Paroxetine when taken with interacting drugs: Pimozide 2 mg, Desipramine 100 mg, Propranolol 80 mg twice daily, Digoxin 0.25 mg once daily, and Phenytoin 300 mg. The x-axis represents change relative to reference on a logarithmic scale from 0.1 to 10.*

FDA Label Image

Principal Display Panel (25 mg Tablet Bottle Label)

A chart showing fold change and 90% confidence interval for the pharmacokinetic parameters Cmax and AUC of several interacting drugs relative to a reference. Drugs listed include Cimetidine 300 mg, Phenobarbital 100 mg, Phenytoin 300 mg, Digoxin 0.25 mg, and Diazepam 5 mg, with corresponding Cmax and AUC fold change values plotted as points with error bars along a scale from 0 to 2.*

FDA Label Image

Principal Display Panel (37.5 mg Tablet Bottle Label)

A pharmacokinetic plot showing fold changes with 90% confidence intervals for paroxetine in various populations. The x-axis represents the change relative to reference on a logarithmic scale from 0.5 to 50. Categories include renal impairment (mild, moderate, severe), hepatic impairment, age groups (>65 years) with different doses, and gender (males). Data points represent Cmax, AUC, and Cmin values with error bars.*

FDA Label Image

Paroxetine 05

Paroxetine Extended-Release Tablets, USP 12.5 mg, with 30 tablets per bottle, labeled for prescription use only by Rhodes Pharmaceuticals LLC. The label includes usage instructions, warnings to keep medication out of reach of children, and manufacturer information, along with the NDC number 42858-703-03 and a barcode.*

FDA Label Image

Paroxetine 06

Paroxetine Extended-Release Tablets, USP 25 mg, 30 count bottle label from Rhodes Pharmaceuticals LLC. The label includes dosage form, strength, NDC 42858-705-03, and directions for pharmacists to dispense the Medication Guide. It also features storage instructions, manufacturer and distributor information, and a barcode.*

FDA Label Image

Paroxetine 07

Paroxetine Extended-Release Tablets, USP 37.5 mg label from Rhodes Pharmaceuticals LLC. The label indicates the product is an extended-release coated tablet containing 37.5 mg of paroxetine hydrochloride. It is a 30-tablet pack with directions for pharmacists to dispense the accompanying medication guide. The label includes usage instructions, storage conditions, and manufacturer information, along with an NDC barcode 42858-707-03.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.